Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.32 |
| ▸ | KDM4A | O75164 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | EPAS1 | Q99814 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.30 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11076906 | 1.00 | LMNA (0.50) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL10453435 | 1.00 | LMNA (0.50) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL10372645 | 1.00 | LMNA (0.50) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL5883624 | 1.00 | LMNA (0.50) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL8177806 | 1.00 | LMNA (0.50) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL4921966 | 1.00 | LMNA (0.50) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL3098719 | 1.00 | LMNA (0.50) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL31179791 | 1.00 | LMNA (0.50) | LMNAKDM4CKDM4APHF8KDM2A | |
| SCHEMBL3180801 | 1.00 | — | — | |
| SCHEMBL11071034 | 1.00 | LMNA (0.50) | LMNAKDM4CKDM4APHF8KDM2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4684045-A1 | AREA SELECTIVE DEPOSITION OF METAL FILM ON SILICON CONTAINING SURFACES UTILIZING HALIDES | Versum Materials US, LLC (US) | 2026-01-28 | — | — | EP | claimed |
| WO-2024215931-A1 | AREA SELECTIVE DEPOSITION OF METAL FILM ON SILICON CONTAINING SURFACES UTILIZING HALIDES | VERSUM MATERIALS US, LLC (US) | 2024-10-17 | — | — | WO | claimed |
| EP-4684045-A1 | AREA SELECTIVE DEPOSITION OF METAL FILM ON SILICON CONTAINING SURFACES UTILIZING HALIDES | Versum Materials US, LLC (US) | 2026-01-28 | — | — | EP | disclosed |
| WO-2024215931-A1 | AREA SELECTIVE DEPOSITION OF METAL FILM ON SILICON CONTAINING SURFACES UTILIZING HALIDES | VERSUM MATERIALS US, LLC (US) | 2024-10-17 | — | — | WO | disclosed |
| CN-111954848-B | Photosensitive resin composition, cured product, insulating material, resin material for solder resist, and resist member | DIC株式会社 | 2024-05-03 | — | — | CN | disclosed |
| CN-114409564-B | Compound containing trityl structure and application thereof | 广州同隽医药科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-112011014-B | Resin composition and use thereof | 台燿科技股份有限公司 | 2022-11-22 | — | — | CN | disclosed |
| CN-109153653-B | Novel compound, photocurable composition, cured product thereof, printing ink, and printed matter using the printing ink | DIC株式会社 | 2022-06-28 | — | — | CN | disclosed |
| CN-114409564-A | Compound containing trityl structure and application thereof | 广州同隽医药科技有限公司 | 2022-04-29 | — | — | CN | disclosed |
| US-11124613-B2 | Resin composition and uses of the same | TAIWAN UNION TECHNOLOGY CORPORATION (TW) | 2021-09-21 | — | — | US | disclosed |
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | DIC CORPORATION (JP) | 2021-08-03 | — | — | US | disclosed |
| US-20190137872-A1 | NOVEL COMPOUND, PHOTOCURABLE COMPOSITION, CURED PRODUCT OF SAME, PRINTING INK, AND PRINTED MATTER SURING THE PRINTING INK | DIC CORPORATION (JP) | 2019-05-09 | — | — | US | disclosed |
| US-5886005-A | 4-Aza-19-norandrostane derivatives | MERCK & CO., INC. (US) | 1999-03-23 | — | — | US | disclosed |
| EP-0804205-A4 | 4-AZA-19-NORANDROSTANE DERIVATIVES | MERCK & CO INC (US) | 1998-05-20 | — | — | EP | disclosed |
| EP-0804205-A1 | 4-AZA-19-NORANDROSTANE DERIVATIVES | Merck & Co., Inc. (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1996022100-A1 | 4-AZA-19-NORANDROSTANE DERIVATIVES | MERCK & CO., INC. (US) | 1996-07-25 | — | — | WO | disclosed |
| US-5478539-A | Solvent extraction by complexing the metal oxyanion with a benzimidazole | ZENECA LIMITED (GB) | 1995-12-26 | — | — | US | disclosed |
| US-5213777-A | Extraction of uranium values using an imidazole extractant | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-05-25 | — | — | US | disclosed |
| US-4209419-A | Certain sulfonamidoquinolines, metal complexes thereof, and solutions containing such sulfonamidoquinolines and metal complexes | HENKEL CORPORATION (US) | 1980-06-24 | — | — | US | disclosed |
| US-4100163-A | Substituted 8-sulfonamidoquinolines | GENERAL MILLS CHEMICALS, INC. (US) | 1978-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11079675-B2 | Compound, photocurable composition, cured product of same, printing ink, and printed matter curing the printing ink | EPB41, F12, CDK1 | LMNA 740/4885KDM4C 37/4885KDM4A 34/4885 |
| US-20190137872-A1 | NOVEL COMPOUND, PHOTOCURABLE COMPOSITION, CURED PRODUCT OF SAME, PRINTING INK, AND PRINTED MATTER SURING THE PRINTING INK | EPB41, CDK1, CDKN1A | LMNA 926/4885KDM4C 42/4885KDM4A 61/4885 |
| US-11124613-B2 | Resin composition and uses of the same | C9, RAD51, F12 | LMNA 994/4885KDM4C 644/4885KDM4A 717/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.